Related Experiment Video
Updated: Jan 9, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Chronic Inflammation in Patients with Chronic Coronary Syndrome Who Have Been Taking Lipid-Lowering Drugs as a
Runze Zhu1,2,3, Wenxian Wang1,2,3, Yan Gao2,3
1School of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
Insights
In patients with chronic coronary syndrome on statins, high systemic inflammation (SIRI) and epicardial adipose tissue (EAT) volume are key risk factors for adverse events. These factors interact, worsening prognosis beyond lipid levels.
Area of Science:
- Cardiology
- Biomedical research
- Inflammation research
Background:
- Patients with coronary heart disease on long-term lipid-lowering agents often have low lipid levels but remain at risk due to systemic inflammation.
- Elevated systemic inflammation is a significant risk factor for poor prognosis in individuals with chronic coronary syndrome (CCS).
Purpose of the Study:
- To investigate the relationship between systemic inflammation and adverse outcomes in CCS patients.
- To explore the synergistic interaction between systemic inflammation and epicardial adipose tissue (EAT) in CCS patients.
Main Methods:
- A retrospective cohort study of 278 CCS patients on long-term statin therapy.
- Cardiovascular magnetic resonance (CMR) imaging and blood tests were used to measure EAT volume and systemic inflammatory response index (SIRI).
- Cox regression and mediation analyses were employed to assess associations and interrelationships.
Main Results:
- Both SIRI and indexed EAT volume were independently associated with major adverse cardiovascular events (MACEs).
- Combining SIRI and EAT volume improved MACE prediction.
- EAT volume and SIRI showed a bidirectional partial mediation effect on MACEs and extracellular volume (ECV).
Conclusions:
- Elevated SIRI and increased EAT volume are critical risk factors in CCS patients on statins, surpassing lipid levels.
- SIRI and EAT volume interact, collectively contributing to a poor prognosis in this patient group.
Background:
Patients with coronary heart disease on long-term lipid-lowering agents typically maintain relatively low lipid levels. However, an elevated systemic inflammatory state represents another major risk factor for poor prognosis in these individuals. This study aims to investigate the relationship between systemic inflammation and adverse outcomes in patients with chronic coronary syndrome(CCS), as well as its synergistic interaction with epicardial adipose tissue (EAT).
Methods:
This is a double-center retrospective cohort study. From March 2017 to September 2023, We retrospectively included 278 patients with CCS from two medical institutions in China, all of whom had been receiving long-term statin therapy. Participants underwent cardiovascular magnetic resonance (CMR) imaging and blood testing. Systemic inflammatory response index (SIRI) were derived, and CMR parameters, including EAT volume, were measured. Cox regression analysis was used to evaluate the association between each variable and major adverse cardiovascular events (MACEs). Mediation analysis was applied to assess the interrelationships among systemic inflammatory markers, indexed EAT volume, and CMR parameters.
Results:
Both the SIRI and indexed EAT volume were independently associated with MACEs. Combining SIRI and indexed EAT volume significantly improved the predictive capacity for MACEs. EAT volume partially mediated the relationship between SIRI and MACEs, and similarly, SIRI partially mediated the association between EAT volume and MACEs. Additionally, we observed analogous interrelationships among SIRI, indexed EAT volume, and extracellular volume (ECV).
Conclusion:
In patients with CCS on long-term statin therapy, elevated SIRI and increased EAT volume represent more important risk factors than lipid levels. SIRI and EAT volume interact with each other and collectively contribute to a poor prognosis in these patients.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...